Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley Sells 25,279 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 25,279 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $457,044.32. Following the transaction, the chief financial officer now directly owns 881,841 shares in the company, valued at approximately $15,943,685.28. The trade was a 2.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Richard Scott Blackley also recently made the following trade(s):

• On Friday, September 6th, Richard Scott Blackley sold 29,957 shares of Oscar Health stock. The stock was sold at an average price of $17.06, for a total transaction of $511,066.42.

Oscar Health Trading Down 2.4 %

NYSE:OSCR opened at $17.99 on Wednesday. The company has a market cap of $4.45 billion, a PE ratio of -299.78 and a beta of 1.63. The business’s 50 day moving average is $17.25 and its two-hundred day moving average is $17.97. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $7.50 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the business earned ($0.29) earnings per share. The business’s revenue for the quarter was up 68.3% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Neo Ivy Capital Management acquired a new stake in Oscar Health during the third quarter worth about $600,000. Geode Capital Management LLC grew its holdings in shares of Oscar Health by 11.7% during the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after purchasing an additional 455,205 shares during the last quarter. Barclays PLC grew its holdings in shares of Oscar Health by 217.5% during the third quarter. Barclays PLC now owns 325,818 shares of the company’s stock valued at $6,911,000 after purchasing an additional 223,189 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in shares of Oscar Health during the 3rd quarter worth approximately $2,764,000. Finally, Soros Fund Management LLC bought a new stake in shares of Oscar Health in the 3rd quarter worth approximately $12,726,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

OSCR has been the subject of several recent analyst reports. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler restated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Finally, UBS Group initiated coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.